Summary of Drugs and Manners of Administration Subject to Price Disclosure
pre-1 December 2010

Please note: The information on this page is no longer current and is only included here for historical reference. Up to date information can be found on the Price Disclosure (EAPD) page.

First Round of PBS Price Disclosure – Assessed for potential reduction on 1 December 2009
First Round of PBS Price Disclosure - December 2009
Drug	MOA
amisulpride	oral
doxorubicin	injection/intravesical
fosinopril with hydrochlorothiazide	oral
meloxicam	oral
mitozantrone	injection
ondansetron	injection
oxybutynin	oral
perindopril with indapamide	oral
valproic acid	oral

Second Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2010
Second Round of PBS Price Disclosure – April 2010
Drug	MOA
alendronic acid	oral
ceftriaxone	injection
fluconazole	injection
fluconazole	oral
naltrexone	oral
vancomycin	injection

Third Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2010
Third Round of PBS Price Disclosure – April 2010
Drug	MOA
carvedilol	oral
enalapril with hydrochlorothiazide	oral
irinotecan	injection
sumatriptan	oral

Fourth Round of PBS Price Disclosure – Assessed for potential reduction on 1 August 2010
Fourth Round of PBS Price Disclosure – August 2010
Drug	MOA
amisulpride	oral
bicalutamide	oral
cefalotin	injection
doxorubicin	injection/intravesical
fosinopril with hydrochlorothiazide	oral
meloxicam	oral
mitozantrone	injection
ondansetron	injection
oxybutynin	oral
perindopril with indapamide	oral
valproic acid	oral

Fifth Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2011
Fifth Round of PBS Price Disclosure – April 2011
Drug	MOA
alendronic acid	oral
ceftriaxone	injection
cisplatin	injection
fluconazole	injection
fluconazole	oral
fludarabine	injection
naltrexone	oral
risperidone	oral
vancomycin	injection

Sixth Round of PBS Price Disclosure – Assessed for potential reduction on 1 April 2011
Sixth Round of PBS Price Disclosure – April 2011
Drug	MOA
carvedilol	oral
enalapril with hydrochlorothiazide	oral
gemcitabine	injection
irinotecan	injection
paclitaxel	injection
sumatriptan	oral
vinorelbine	injection

Seventh Round of PBS Price Disclosure – Assessed for potential reduction on 1 August 2011
Seventh Round of PBS Price Disclosure – August 2011
Drug	MOA
alendronic acid with colecalciferol	oral
amisulpride	oral
azithromycin	oral
bicalutamide	oral
bisoprolol	oral
cabergoline	oral
cefalotin	injection
doxorubicin	injection/intravesical
escitalopram	oral
fosinopril with hydrochlorothiazide	oral
glucose	injection
meloxicam	oral
mitozantrone	injection
morphine	oral
ondansetron	injection
ondansetron	oral
oxaliplatin	injection
oxybutynin	oral
perindopril with indapamide	oral
sodium chloride	injection
sodium lactate compound	injection
valproic acid	oral

This list includes all drugs and manners of administration subject to price disclosure arrangements in each cycle pre-1 December 2010 (i.e. prior to arrangements becoming expanded and accelerated).

Summary of Drugs and Manners of Administration Subject to Price Disclosure
pre-1 December 2010

Department of Health, Disability and Ageing

Pharmaceutical Benefits Scheme

PBS Information

Browse the PBS

For Health Professionals

For Industry

Summary of Drugs and Manners of Administration Subject to Price Disclosure pre-1 December 2010

Summary of Drugs and Manners of Administration Subject to Price Disclosure
pre-1 December 2010